Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Daridorexant hydrochloride by Idorsia Pharmaceutical for Post-Traumatic Stress Disorder (PTSD): Likelihood of Approval
Daridorexant hydrochloride is under clinical development by Idorsia Pharmaceutical and currently in Phase II for Post-Traumatic Stress Disorder (PTSD). According...
Data Insights
Daridorexant hydrochloride by Idorsia Pharmaceutical for Obstructive Sleep Apnea: Likelihood of Approval
Daridorexant hydrochloride is under clinical development by Idorsia Pharmaceutical and currently in Phase I for Obstructive Sleep Apnea. According to...